Schwartz PE - Search Results

1

Prognostic factors and sites of failure in FIGO Stage I, Grade 3 endometrial carcinoma.

Chambers SK, Kapp DS, Peschel RE, Lawrence R, Merino M, Kohorn EI, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1987 Jun;27(2):180-8. doi: 10.1016/0090-8258(87)90291-5. Gynecol Oncol. 1987. PMID: 3570056

2

Neoadjuvant chemotherapy in stage X ovarian carcinoma.

Chambers JT, Chambers SK, Voynick IM, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Jun;37(3):327-31. doi: 10.1016/0090-8258(90)90361-n. Gynecol Oncol. 1990. PMID: 2351315

3

Radiation treatment of FIGO stage IVA carcinoma of the cervix.

Kramer C, Peschel RE, Goldberg N, Kohorn EI, Chambers JT, Chambers SK, Schwartz PE. Kramer C, et al. Among authors: schwartz pe. Gynecol Oncol. 1989 Mar;32(3):323-6. doi: 10.1016/0090-8258(89)90633-1. Gynecol Oncol. 1989. PMID: 2920952

4

Adjuvant therapy in mixed mullerian tumors of the uterus.

Kohorn EI, Schwartz PE, Chambers JT, Peschel RE, Kapp DS, Merino M. Kohorn EI, et al. Among authors: schwartz pe. Gynecol Oncol. 1986 Feb;23(2):212-21. doi: 10.1016/0090-8258(86)90226-x. Gynecol Oncol. 1986. PMID: 3002919

5

Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer.

Chambers JT, MacLusky N, Eisenfield A, Kohorn EI, Lawrence R, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1988 Sep;31(1):65-81. doi: 10.1016/0090-8258(88)90270-3. Gynecol Oncol. 1988. PMID: 3410357

6

Stage IIIA carcinoma of the uterine cervix.

Cardinale JG, Peschel RE, Gutierrez E, Kapp DS, Kohorn EI, Schwartz PE. Cardinale JG, et al. Among authors: schwartz pe. Gynecol Oncol. 1986 Feb;23(2):199-204. doi: 10.1016/0090-8258(86)90224-6. Gynecol Oncol. 1986. PMID: 3943762

7

Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium.

Fishman DA, Roberts KB, Chambers JT, Kohorn EI, Schwartz PE, Chambers SK. Fishman DA, et al. Among authors: schwartz pe. Gynecol Oncol. 1996 May;61(2):189-96. doi: 10.1006/gyno.1996.0123. Gynecol Oncol. 1996. PMID: 8626131 Free article.

8

Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients.

Chambers SK, Chambers JT, Holm C, Peschel RE, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Nov;39(2):155-9. doi: 10.1016/0090-8258(90)90424-j. Gynecol Oncol. 1990. PMID: 2121629 Clinical Trial.

9

Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.

Chambers SK, Flynn SD, Del Prete SA, Chambers JT, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1989 Mar;32(3):303-9. doi: 10.1016/0090-8258(89)90629-x. Gynecol Oncol. 1989. PMID: 2465939

10

CHAP II therapy for epithelial ovarian cancers following primary treatment with platinum-based combination chemotherapy.

Schwartz PE, Keating G, Kohorn EI, Chambers JT. Schwartz PE, et al. Gynecol Oncol. 1986 Nov;25(3):340-6. doi: 10.1016/0090-8258(86)90085-5. Gynecol Oncol. 1986. PMID: 3096820 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters